Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
History Research involving BPC-157 originated from investigations into naturally occurring protective compounds associated with tissue maintenance and recovery
Class Small-molecule NNMT inhibitor
Its well-characterized molecular structure and reproducible analytical profile make it a valuable investigational peptide for advanced laboratory research
Any peptide therapy decision should be made with a qualified medical provider who screens candidates, monitors progress, and adjusts protocols based on real outcomes
Published preclinical studies have examined BPC-157 across gastrointestinal tissue (NSAID-induced injury, alcohol-induced damage, inflammatory bowel models) (1), tendon and connective tissue (5)(2), muscle and bone models (1), and neurological tissue through brain-gut axis interactions (4)
